VanEck Associates
TWST icon

VanEck Associates’s Twist Bioscience TWST Stock Holding History

VanEck Associates’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,543
Closed -$73K – 1481
2026
Q1 		$73K Sell
1,543
-533
-26% -$23.9K ﹤0.01% 1319
2025
Q4 		$66K Buy
2,076
+1,034
+99% +$32.3K ﹤0.01% 1342
2025
Q3 		$29K Buy
1,042
+216
+26% +$6.54K ﹤0.01% 1361
2025
Q2 		$30K Buy
826
+58
+8% +$2K ﹤0.01% 1343
2025
Q1 		$30K Buy
768
+28
+4% +$1.26K ﹤0.01% 1322
2024
Q4 		$34K Buy
740
+267
+56% +$12.1K ﹤0.01% 1315
2024
Q3 		$19K Sell
473
-187
-28% -$8.9K ﹤0.01% 1316
2024
Q2 		$33K Buy
660
+46
+7% +$1.88K ﹤0.01% 1308
2024
Q1 		$21K Buy
614
+68
+12% +$2.45K ﹤0.01% 1316
2023
Q4 		$20K Sell
546
-82
-13% -$1.9K ﹤0.01% 1335
2023
Q3 		$13K Hold
628
– – ﹤0.01% 1350
2023
Q2 		$13K Sell
628
-154
-20% -$2.31K ﹤0.01% 1358
2023
Q1 		$12K Hold
782
– – ﹤0.01% 1367
2022
Q4 		$19K Buy
782
+230
+42% +$6.67K ﹤0.01% 1365
2022
Q3 		$19K Buy
+552
New +$23.4K ﹤0.01% 1322

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

VanEck Associates's TWST Position: Q2 2026 in Review

VanEck Associates sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 1,543 shares — an estimated $73K sold.

VanEck Associates first reported a position in TWST in Q3 2022 and held it in 15 quarters. The position peaked at $73K in Q1 2026. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • VanEck Associates reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 1,543 Twist Bioscience shares in Q2 2026, an estimated $73K.
  • VanEck Associates first reported a position in Twist Bioscience in Q3 2022 and held it in 15 quarters.
  • VanEck Associates's Twist Bioscience position peaked at $73K in Q1 2026.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.